Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov;10(Suppl 33):S3831-S3833.
doi: 10.21037/jtd.2018.10.14.

Prophylaxis with amiodarone for postoperative atrial fibrillation: when and who?

Affiliations
Editorial

Prophylaxis with amiodarone for postoperative atrial fibrillation: when and who?

Willemijn F B van der Does et al. J Thorac Dis. 2018 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

Similar articles

Cited by

References

    1. Lahtinen J, Biancari F, Salmela E, et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004;77:1241-4. 10.1016/j.athoracsur.2003.09.077 - DOI - PubMed
    1. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9. 10.1001/jama.291.14.1720 - DOI - PubMed
    1. El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol 2010;55:1370-6. 10.1016/j.jacc.2009.10.058 - DOI - PubMed
    1. Mehaffey JH, Hawkins RB, Byler M, et al. Amiodarone Protocol Provides Cost-Effective Reduction in Postoperative Atrial Fibrillation. Ann Thorac Surg 2018;105:1697-702. 10.1016/j.athoracsur.2017.12.029 - DOI - PMC - PubMed
    1. Gillespie EL, White CM, Kluger J, et al. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2006;26:499-504. 10.1592/phco.26.4.499 - DOI - PubMed